I think the most important piece of work done was the TOSCA study, which looked at health needs in Toronto for injection drug users and what the health benefits would be of the implementation of that service. It did demonstrate that with a model of supervised injection embedded with other primary health services that serve drug users, three sites, for example, would provide a significant benefit in the areas in which the sites were located. That was a feasibility study, if you like, that incorporated a large amount of information about drug use in the community, the impact of supervised injection, infectious disease rates, and overdose. It took us much closer to a model that I think is suitable for our patterns of drug use.
There really is no area in Toronto that is like the downtown eastside in Vancouver, and the InSite model is not appropriate, in my view, for the patterns of drug use in Toronto. However, embedding supervised injection as a service with other primary health services, in community health centres, in existing harm reduction services, I think is very appropriate. That's the direction in which the board of health has pointed us.